A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy
Phase of Trial: Phase I
Latest Information Update: 18 Apr 2019
Price : $35 *
At a glance
- Drugs Capecitabine (Primary) ; Entinostat (Primary)
- Indications Advanced breast cancer; Inflammatory breast cancer; Male breast cancer
- Focus Adverse reactions
- Acronyms Breast 49
- 12 Dec 2018 Planned End Date changed from 1 Sep 2028 to 15 Oct 2028.
- 12 Dec 2018 Planned primary completion date changed from 1 Sep 2026 to 15 Oct 2026.
- 31 Oct 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 30 Jun 2018 to 15 Dec 2018.